News | Artificial Intelligence | June 11, 2024

A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and Biology, sheds light on the significant lung damage caused by severe COVID-19. In this image, AI highlights areas of the lungs with architectural distortions. Blue areas indicate mild COVID-19, while red areas indicate severe COVID-19.

A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and Biology, sheds light on the significant lung damage caused by severe COVID-19.

A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and Biology, sheds light on the significant lung damage caused by severe COVID-19. In this image, AI highlights areas of the lungs with architectural distortions. Blue areas indicate mild COVID-19, while red areas indicate severe COVID-19. Image courtesy: Emory University


June 11, 2024 — A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and Biology, has shed light on the significant lung damage caused by severe COVID-19, according to the study authors, who emphasized that as the immediate threat of COVID-19 subsides, investigating the virus’s lasting impacts remains essential.

“Although the acute phase of COVID-19 has largely been mitigated, the persistence and impact of long COVID remains a concern. Our AI analysis identified specific areas of lung damage that could have enduring consequences,” said Anant Madabhushi, PhD, Executive Director of Emory AI.Health and principal investigator of the study. “While we have not yet examined long COVID patients explicitly, it’s crucial to investigate whether these individuals exhibit residual lung deformation, which could provide valuable insights into the long-term effects of this disease,” he added.

About the AI Lung Study

The study, “Deep learning reveals lung shape differences on baseline chest CT between mild and severe COVID-19: A multi-state retrospective study,” utilized artificial intelligence (AI) to analyze CT scans from over 3,400 patients across multiple institutions. These patients were categorized into three groups: healthy individuals, those with mild COVID-19, and those with severe COVID-19 requiring ventilator support.

The analysis revealed that patients with severe COVID-19 experienced significant deformities to the surfaces of the lungs, particularly along the mediastinal and basal surfaces. These findings are critical for understanding the potential long-term effects of the disease. Researchers suggest that these lung deformations are likely to impair lung function, ultimately affecting human health and quality of life, and potentially increasing overall mortality.

The role of AI in lung analysis

The AI technology used in the study employed a 3D residual convolutional network to segment and analyze lung images, according to a written summary of the study issued by Emory University. This approach, it added, allowed researchers to create a detailed map of lung deformations, identifying specific areas of damage. By comparing lung images of healthy individuals with those of mild and severe COVID-19 patients, the AI provided a comprehensive map of lung deformations, highlighting the extent of the damage caused by severe COVID-19.

One of the study's goals was to demonstrate how AI can systematically evaluate the long-term effects of COVID-19 on internal organs. The ability to identify and quantify lung damage through AI not only helps researchers understand the immediate impact of severe COVID-19, but also offers insight into the potential lingering effects on lung function.

“COVID-19 can cause serious complications such as pneumonia, severe lung damage, and blood infections, which can lead to lasting lung problems like scarring and chronic breathing issues,” said Amogh Hiremath, AI scientist at Picture Health and first author of the study. “While some people recover fully, others may suffer permanent lung damage. Understanding how COVID-19 affects the lungs during its early onset can help us better understand and treat the disease,” added Hiremath.

More information: www.emory.eduwww.aihealth.emory.edu

Reference: DOI: 10.1016/j.compbiomed.2024.108643


Related Content

News | Imaging Software Development

June 05, 2025 — Nano-X Imaging Ltd. has announced that its deep-learning medical imaging analytics subsidiary, Nanox AI ...

Time June 05, 2025
arrow
News | Prostate Cancer

June 5, 2025 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time June 05, 2025
arrow
News | Ultrasound Imaging

June 3, 2025 — In a collaborative study between the Departments of Radiology at the Children’s Hospital of Philadelphia ...

Time June 04, 2025
arrow
News | Breast Imaging

June 2, 2025 — Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S ...

Time June 02, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — the Swoop ...

Time May 29, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Imaging Software Development

May 20, 2025 – Intelerad, a provider of medical imaging software solutions, recently announced its prime partnership ...

Time May 21, 2025
arrow
News | Teleradiology

May 21, 2025 — Konica Minolta Healthcare Americas, Inc and NewVue have announced the introduction of Exa Teleradiology ...

Time May 21, 2025
arrow
News | Computed Tomography (CT)

May 15, 2025 — GE HealthCare has launched CleaRecon DL, technology powered by a deep-learning algorithm, to improve the ...

Time May 15, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
Subscribe Now